139 related articles for article (PubMed ID: 1810197)
1. Impact of pH and cationic supplementation on in vitro postantibiotic effect.
Gudmundsson A; Erlendsdottir H; Gottfredsson M; Gudmundsson S
Antimicrob Agents Chemother; 1991 Dec; 35(12):2617-24. PubMed ID: 1810197
[TBL] [Abstract][Full Text] [Related]
2. Postexposure factors influencing the duration of postantibiotic effect: significance of temperature, pH, cations, and oxygen tension.
Fuursted K
Antimicrob Agents Chemother; 1997 Aug; 41(8):1693-6. PubMed ID: 9257743
[TBL] [Abstract][Full Text] [Related]
3. Correlation between bactericidal activity and postantibiotic effect for five antibiotics with different mechanisms of action.
Li RC; Lee SW; Kong CH
J Antimicrob Chemother; 1997 Jul; 40(1):39-45. PubMed ID: 9249203
[TBL] [Abstract][Full Text] [Related]
4. Minimum inhibitory and bactericidal concentrations of 44 antimicrobial agents against three standard control strains in broth with and without human serum.
Reimer LG; Stratton CW; Reller LB
Antimicrob Agents Chemother; 1981 Jun; 19(6):1050-5. PubMed ID: 6791584
[TBL] [Abstract][Full Text] [Related]
5. Postantibiotic effect of ciprofloxacin compared with that of five other quinolones.
Minguez F; Ramos C; Barrientos S; Loscos A; Prieto J
Chemotherapy; 1991; 37(6):420-5. PubMed ID: 1760941
[TBL] [Abstract][Full Text] [Related]
6. The postantibiotic effect induced by antimicrobial combinations.
Gudmundsson S; Erlendsdóttir H; Gottfredsson M; Gudmundsson A
Scand J Infect Dis Suppl; 1990; 74():80-93. PubMed ID: 2129068
[TBL] [Abstract][Full Text] [Related]
7. In vitro postantibiotic effects of tomopenem (CS-023) against Staphylococcus aureus and Pseudomonas aeruginosa.
Tomozawa T; Sugihara C; Kakuta M; Sugihara K; Koga T
J Med Microbiol; 2010 Apr; 59(Pt 4):438-441. PubMed ID: 20093378
[TBL] [Abstract][Full Text] [Related]
8. Different patterns of bacterial DNA synthesis during postantibiotic effect.
Gottfredsson M; Erlendsdóttir H; Gudmundsson A; Gudmundsson S
Antimicrob Agents Chemother; 1995 Jun; 39(6):1314-9. PubMed ID: 7574522
[TBL] [Abstract][Full Text] [Related]
9. Pharmacodynamics of beta-lactam antibiotics. Studies on the paradoxical and postantibiotic effects in vitro and in an animal model.
Odenholt-Tornqvist I
Scand J Infect Dis Suppl; 1989; 58():1-55. PubMed ID: 2499924
[TBL] [Abstract][Full Text] [Related]
10. Isolation and in-vitro and in-vivo characterisation of a mutant of Pseudomonas aeruginosa PAO1 that exhibited a reduced postantibiotic effect in response to imipenem.
Majcherczyk PA; Kunz S; Hattenberger M; Vaxelaire J; Zak O; O'Reilly T
J Antimicrob Chemother; 1994 Oct; 34(4):485-505. PubMed ID: 7646646
[TBL] [Abstract][Full Text] [Related]
11. In vitro antibacterial properties of magnesium metal against Escherichia coli, Pseudomonas aeruginosa and Staphylococcus aureus.
Robinson DA; Griffith RW; Shechtman D; Evans RB; Conzemius MG
Acta Biomater; 2010 May; 6(5):1869-77. PubMed ID: 19818422
[TBL] [Abstract][Full Text] [Related]
12. Postantibiotic effects of imipenem, norfloxacin, and amikacin in vitro and in vivo.
Renneberg J; Walder M
Antimicrob Agents Chemother; 1989 Oct; 33(10):1714-20. PubMed ID: 2511798
[TBL] [Abstract][Full Text] [Related]
13. In vitro killing kinetics and postantibiotic effect of josamycin and other macrolides on several bacteria.
Minguez F; Ramos C; Loscos A; Chiu ML; Prieto J
Chemotherapy; 1993; 39(3):163-8. PubMed ID: 8389685
[TBL] [Abstract][Full Text] [Related]
14. Influence of inoculum size of Staphylococcus aureus and Pseudomonas aeruginosa on in vitro activities and in vivo efficacy of fluoroquinolones and carbapenems.
Mizunaga S; Kamiyama T; Fukuda Y; Takahata M; Mitsuyama J
J Antimicrob Chemother; 2005 Jul; 56(1):91-6. PubMed ID: 15890721
[TBL] [Abstract][Full Text] [Related]
15. Ultrastructural alterations of bacteria during the postantibiotic effect.
Gottfredsson M; Erlendsdóttir H; Kolka R; Gudmundsson A; Gudmundsson S
Chemotherapy; 1993; 39(3):153-62. PubMed ID: 8508685
[TBL] [Abstract][Full Text] [Related]
16. In vivo and in vitro study of several pharmacodynamic effects of meropenem.
Fuentes F; Martín MM; Izquierdo J; Gomez-Lus ML; Prieto J
Scand J Infect Dis; 1995; 27(5):469-74. PubMed ID: 8588137
[TBL] [Abstract][Full Text] [Related]
17. Duration and clinical relevance of postantibiotic effect in relation to the dosing interval.
den Hollander JG; Fuursted K; Verbrugh HA; Mouton JW
Antimicrob Agents Chemother; 1998 Apr; 42(4):749-54. PubMed ID: 9559777
[TBL] [Abstract][Full Text] [Related]
18. Influence of medium and method on the in vitro susceptibility of Pseudomonas aeruginosa and other bacteria to ciprofloxacin and enoxacin.
Blaser J; Dudley MN; Gilbert D; Zinner SH
Antimicrob Agents Chemother; 1986 May; 29(5):927-9. PubMed ID: 2942102
[TBL] [Abstract][Full Text] [Related]
19. Postanitbiotic and sub-MIC effects of azithromycin and isepamicin against Staphylococcus aureus and Escherichia coli.
Fuentes F; Izquierdo J; Martín MM; Gomez-Lus ML; Prieto J
Antimicrob Agents Chemother; 1998 Feb; 42(2):414-8. PubMed ID: 9527796
[TBL] [Abstract][Full Text] [Related]
20. Gepotidacin (GSK2140944)
Flamm RK; Farrell DJ; Rhomberg PR; Scangarella-Oman NE; Sader HS
Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28483959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
